Labile methyl groups and the promotion of cancer.
D000818:Animals; D000917:Antibody Formation; D002273:Carcinogens / Q000378:metabolism; D002794:Choline / Q000378:metabolism; D002796:Choline Deficiency / Q000276:immunology / Q000378:metabolism; D004247:DNA / Q000096:biosynthesis; D004032:Diet; D005492:Folic Acid / Q000378:metabolism; D005494:Folic Acid Deficiency / Q000276:immunology / Q000378:metabolism; D006801:Humans; D007111:Immunity, Cellular; D008082:Lipotropic Agents / Q000008:administration & dosage / Q000172:deficiency*; D008099:Liver / Q000378:metabolism; D008113:Liver Neoplasms / Q000209:etiology / Q000473:pathology; D008715:Methionine / Q000172:deficiency / Q000378:metabolism; D008745:Methylation; D009369:Neoplasms / Q000209:etiology*; D009374:Neoplasms, Experimental / Q000209:etiology; D004364:Pharmaceutical Preparations / Q000378:metabolism; D012306:Risk; D013763:Tetrahydrofolates / Q000378:metabolism; D014805:Vitamin B 12 / Q000378:metabolism; D014806:Vitamin B 12 Deficiency / Q000276:immunology / Q000378:metabolism
D002273:Carcinogens; D008082:Lipotropic Agents; D004364:Pharmaceutical Preparations; D013763:Tetrahydrofolates; C030371:5,6,7,8-tetrahydrofolic acid; D004247:DNA; D005492:Folic Acid; D008715:Methionine; D002794:Choline; D014805:Vitamin B 12